Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 20.

Gerber, B; Alberio, L; Rochat, S; Stenner, F; Manz, M G; Buser, A; Schanz, U; Stussi, G (2016). Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies. Transfusion, 56(10):2426-2437.

Güngör, T; Teira, P; Slatter, M; Stussi, G; Stepensky, P; Moshous, D; Vermont, C; Ahmad, I; Shaw, P J; da Cunha, J M; Schlegel, P G; Hough, R; Fasth, A; Kentouche, K; Gruhn, B; Fernandes, J F; Lachance, S; Bredius, R; Resnick, I B; Belohradsky, B H; Gennery, A; Fischer, A; Gaspar, H B; Schanz, U; Seger, R; Rentsch, K; Veys, P; Haddad, E; Albert, M H; Hassan, M (2014). Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet, 383(9915):436-448.

Kirsch, M; Götz, A; Halter, J P; Schanz, U; Stussi, G; Dobbels, F; De Geet, S (2014). Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study. Bone Marrow Transplantation, 49(9):1223-1230.

Berger, M D; Meisel, A; Andres, M; Schanz, U; Schwarz, U; Stussi, G (2014). Unusual case of progressive multifocal leukoencephalopathy after allogeneic hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 32(9):e33-e34.

Benz, R; Schanz, U; Maggiorini, M; Seebach, J D; Stussi, G (2014). Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplantation, 49(1):62-65.

Marek, A; Stern, M; Chalandon, Y; Ansari, M; Ozsahin, H; Güngör, T; Gerber, B; Kühne, T; Passweg, J R; Gratwohl, A; Tichelli, A; Seger, R; Schanz, U; Halter, J; Stussi, G (2014). The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT. Bone Marrow Transplantation, 49(1):55-61.

Passweg, J R; Baldomero, H; Bargetzi, M; Bucher, C; Chalandon, Y; Duchosal, M A; Gratwohl, A; Güngör, T; Hess, U; Leibundgut, K; de Faveri, G N; Ozsahin, H; Pabst, T; Renner, C; Stern, M; Stussi, G; Schanz, U (2013). Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries. Swiss Medical Weekly, 143:w13757.

Gerull, S; Stern, M; Ben Aissa, A; Manz, M G; Schanz, U; Stussi, G; Chalandon, Y; Passweg, J; Mohty, B (2013). Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT. Bone Marrow Transplantation, 48(3):408-413.

Bettens, F; Passweg, J; Schanz, U; Chalandon, Y; Heim, D; Güngör, T; Stussi, G; Nicoloso, G; Baldomero, H; Gratwohl, A; Tiercy, J M (2012). Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms. Biology of Blood and Marrow Transplantation, 18(4):608-616.

Berger, M D; Gerber, B; Arn, K; Senn, O; Schanz, U; Stussi, G (2012). Significant reduction of red blood cell transfusion requirements by changing from double- to single-unit transfusion policy in patients receiving intensive chemotherapies or stem cell transplantation. Haematologica, 97(1):116-122.

Zeidler, K; Arn, K; Senn, O; Schanz, U; Stussi, G (2011). Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia. Transfusion, 51(11):2269-2276.

Arn, K D; Dazzi, H; Went, P; Goede, J S; Stussi, G (2011). Erythroleukaemia at second glance. European Journal of Haematology, 86(4):358-359.

Stussi, G; Halter, J; Tichelli, A; Meyer-Monard, S; Arber, C; Heim, D (2010). Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies. Bone Marrow Transplantation, 45(1):103-109.

Rovo, A; Stussi, G; Meyer-Monard, S; Favre, G; Tsakiris, D; Heim, D; Halter, J; Arber, C; Passweg, J; Gratwohl, A; Tichelli, A (2010). Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood. International Journal of Laboratory Hematology, 32(3):329-335.

Cusini, A; Günthard, H F; Stussi, G; Schwarz, U; Fehr, T; Grueter, E; Meerbach, A; Bossart, W; Schaer, D J; Rudiger, A (2010). Hemophagocytic syndrome caused by primary herpes simplex virus 1 infection: report of a first case. Infection, 38(5):423-426.

Young, M; Rodak, R; Stussi, G; Beck, B (2009). Eosinophilie - Differentialdiagnose und Abklärung. Praxis, 98(15):797-806.

Stussi, G; Tichelli, A; Schanz, U; Goede, J (2009). Hypereosinophilia with a low blast count as the initial manifestation of acute myeloid leukaemia with RUNX1-RUNX1T1. British Journal of Haematology, 146(4):346.

Benz, R; Siciliano, R D; Stussi, G; Fehr, J (2009). Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia. European Journal of Haematology, 82(3):194-200.

Stussi, G; Halter, J; Bucheli, E; Valli, P V; Seebach, L; Gmür, J; Gratwohl, A; Passweg, J R; Seebach, J D (2009). Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins. Haematologica, 94(2):239-248.

Hochholzer, W; Vavricka, S R; Stussi, G; Adams, H; Wruk, D; Battegay, E; Zimmerli, L U (2008). Diffuse Bauchschmerzen und Eosinophilie. Der Internist, 49(11):1379-1382.

This list was generated on Sat Dec 16 09:01:11 2017 CET.